Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
New research from the University of Copenhagen points to an entirely new approach for designing insulin-based pharmaceuticals. The approach could open the door for more personalized medications with fewer side effects for Type 1 Diabetes patients.
Knud J. Jensen is a professor at the University of Copenhagen's Department of Chemistry. Together with Technical University of Denmark (DTU) and Novo Nordisk researchers, he has published "Construction of Insulin 18-mer Nanoassemblies Driven by Coordination to Iron (II) and Zink (II) Ions at Distinct Sites" in the renowned journal, Angewandte Chemie.
"We have discovered an entirely new method of modifying a molecule - Insulin - that is important for 35 million diabetes patients. We are incredibly happy with that," says Professor Jensen.
http://www.eurekalert.org/pub_releases/2016-02/fos--ctp021816.php
Hmm...perhaps someone should tell them that, actually, basal rates aren't uniform throughout the day, hence the facility to tune them by the hour on pumps... 🙄
Knud J. Jensen is a professor at the University of Copenhagen's Department of Chemistry. Together with Technical University of Denmark (DTU) and Novo Nordisk researchers, he has published "Construction of Insulin 18-mer Nanoassemblies Driven by Coordination to Iron (II) and Zink (II) Ions at Distinct Sites" in the renowned journal, Angewandte Chemie.
"We have discovered an entirely new method of modifying a molecule - Insulin - that is important for 35 million diabetes patients. We are incredibly happy with that," says Professor Jensen.
http://www.eurekalert.org/pub_releases/2016-02/fos--ctp021816.php
Hmm...perhaps someone should tell them that, actually, basal rates aren't uniform throughout the day, hence the facility to tune them by the hour on pumps... 🙄
